IDE2 is a small molecule inducer of definitive endoderm from embryonic stem cells; it is used in organ transplantation and differentiation studies. It activates the TGF-β signaling pathway to induce Sox17+/FoxA2+-expressing pancreatic progenitor cells from human and mouse embryonic stem cells (EC50 = 223 nM, in vitro). IDE2-derived endoderm cells have been shown to incorporate into the developing gut tube of E8.75 mouse embryos ex vivo, contributing to gut formation. Furthermore, when combined with standard protocols involving indolactam V, growth factor FGF-10, retinoic acid, and hedgehog inhibitors, IDE2-induced endoderm cells can differentiate into Pdx1-expressing pancreatic progenitor cells.